Adding Cetuximab Harmful in Esophageal Cancer Treatment

SAN FRANCISCO (IMNG) - A phase II/III clinical trial of adding cetuximab to chemoradiotherapy for localized esophageal cancer was stopped early when interim results showed greater toxicity, less completion...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news